Production of a novel influenza vaccine using insect cells: protection against drifted strains
- PMID: 19453478
- PMCID: PMC4634664
- DOI: 10.1111/j.1750-2659.2006.00007.x
Production of a novel influenza vaccine using insect cells: protection against drifted strains
Abstract
A recombinant trivalent hemagglutinin (HA) vaccine produced in cell culture using the baculovirus expression system provides an attractive alternative to the current egg-based influenza vaccine (Trivalent Inactivated Influenza Vaccine [TIV]) manufacturing process. The HA genes from the annual World Health Organization-recommended strains are cloned, expressed, and purified using a general purification process. Here, we provide an overview of the expression technology used to make the annual adjustment of the vaccine and the clinical studies completed to date with recombinant HA. The highly purified protein vaccine, administered at three times higher antigen content than TIV, results in stronger immunogenicity, a long-lasting immune response and provides cross-protection against drift variant influenza viruses. Furthermore, the vaccine does not contain egg proteins, adjuvants, preservatives, endotoxins, or antibiotics and can therefore be used in a broader population.
Similar articles
-
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.J Virol. 2011 Mar;85(6):3010-4. doi: 10.1128/JVI.01241-10. Epub 2010 Dec 29. J Virol. 2011. PMID: 21191017 Free PMC article.
-
FluBlok, a next generation influenza vaccine manufactured in insect cells.Biologicals. 2009 Jun;37(3):182-9. doi: 10.1016/j.biologicals.2009.02.014. Epub 2009 Mar 17. Biologicals. 2009. PMID: 19297194 Review.
-
Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.Vaccine. 1999 Apr 9;17(15-16):2073-80. doi: 10.1016/s0264-410x(98)00413-7. Vaccine. 1999. PMID: 10217609
-
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.J Infect Dis. 2006 May 1;193(9):1223-8. doi: 10.1086/503050. Epub 2006 Mar 28. J Infect Dis. 2006. PMID: 16586358 Clinical Trial.
-
Recombinant hemagglutinin influenza vaccine provides broader spectrum protection.Expert Rev Vaccines. 2016 Aug;15(8):957-66. doi: 10.1080/14760584.2016.1203261. Epub 2016 Jul 4. Expert Rev Vaccines. 2016. PMID: 27314982 Review.
Cited by
-
Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.PLoS One. 2016 Jul 27;11(7):e0159709. doi: 10.1371/journal.pone.0159709. eCollection 2016. PLoS One. 2016. PMID: 27463224 Free PMC article.
-
Developments of subunit and VLP vaccines against influenza A virus.Virol Sin. 2012 Jun;27(3):145-53. doi: 10.1007/s12250-012-3241-1. Epub 2012 Jun 9. Virol Sin. 2012. PMID: 22684468 Free PMC article. Review.
-
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0].J Prev Med Hyg. 2023 Mar 2;63(4 Suppl 1):E1-E140. doi: 10.15167/2421-4248/jpmh2022.63.4s1. eCollection 2022 Dec. J Prev Med Hyg. 2023. PMID: 37034835 Free PMC article. Italian. No abstract available.
-
FluBlok, a recombinant hemagglutinin influenza vaccine.Influenza Other Respir Viruses. 2008 Nov;2(6):211-9. doi: 10.1111/j.1750-2659.2008.00053.x. Influenza Other Respir Viruses. 2008. PMID: 19453397 Free PMC article. Review.
-
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.J Virol. 2011 Mar;85(6):3010-4. doi: 10.1128/JVI.01241-10. Epub 2010 Dec 29. J Virol. 2011. PMID: 21191017 Free PMC article.
References
-
- Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 1982;4:24–44. - PubMed
-
- Centers for Disease Control (CDC) . ACIP. Prevention and control of influenza, recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2002;51:1–31. - PubMed
-
- Chiron Vaccines . Agrippal Product Monograph. Starnberg, Germany: Adis International Limited, 2002.
-
- Heimpel A, Thomas ED, Adams JR, Smith LJ. The presence of nuclear polyhedrosis virus of Trichoplusia ni on cabbage from the market shelf. Environ Ent 1973;2:72–76.
-
- Tinsley TW, Harrap KA. Viruses of invertebrates; in Fraenkel‐Conrat H, Wagner RR. (ed): Comprehensive Virology, Vol. 12. New York: Plenum Press, 1978; 1–101.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical